Sveriges Riksbank
Share
RESULT OF RIKSBANK REVERSED AUCTIONS SEK GOVERNMENT BONDS
| Auction date | 2021-02-26 |
| Loan | 1053 |
| Coupon | 3.5 % |
| ISIN-code | SE0002829192 |
| Maturity | 2039-03-30 |
| Tendered volume, SEK mln | 1,000 +/- 500 |
| Volume offered, SEK mln | 1,500 |
| Volume bought, SEK mln | 1,000 |
| Number of bids | 6 |
| Number of accepted bids | 5 |
| Average yield | 0.700 |
| Lowest accepted yield | 0.681 |
| Highest yield | 0.737 |
| % accepted at lowest yield | 100.00 |
| Auction date | 2021-02-26 |
| Loan | 1063 |
| Coupon | 0.5 % |
| ISIN-code | SE0015193313 |
| Maturity | 2045--24 |
| Tendered volume, SEK mln | 500 +/- 250 |
| Volume offered, SEK mln | 1,000 |
| Volume bought, SEK mln | 500 |
| Number of bids | 5 |
| Number of accepted bids | 4 |
| Average yield | 0.879 |
| Lowest accepted yield | 0.867 |
| Highest yield | 0.897 |
| % accepted at lowest yield | 100.00 |
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
DK
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Bavarian Nordic A/S1.11.2025 10:34:34 CET | Press release
Bavarian Nordic Provides Clarification on the HERA Framework Agreement and the Public Preparedness Business
Bavarian Nordic A/S1.11.2025 10:34:34 CET | Pressemeddelelse
Bavarian Nordic præciserer HERA rammeaftalen og Public Preparedness forretningen
Teva Pharmaceutical Industries Ltd31.10.2025 21:30:00 CET | Press release
Teva to Present at UBS Global Healthcare Conference and Jefferies London Healthcare Conference in November
Verkkokauppa.com Oyj31.10.2025 18:00:00 CET | Press release
Verkkokauppa.com Oyj: Acquisition of own shares on 31 October 2025
Ress Life Investments A/S31.10.2025 17:55:00 CET | Press release
Ress Life Investments A/S publishes Net Asset Value (NAV).
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom